IbuprofenAspirinCyclooxygenase InhibitorsCyclooxygenase 2Cyclooxygenase 1Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 InhibitorsProstaglandin-Endoperoxide SynthasesPlatelet Aggregation InhibitorsIndomethacinThromboxane B2DinoprostoneProstaglandinsAcetaminophenNaproxenAnalgesics, Non-NarcoticArachidonic AcidSalicylatesPlatelet AggregationIsoenzymesDiclofenacTiclopidineThromboxanesPyrazolesSulfonamides6-Ketoprostaglandin F1 alphaNitrobenzenesFlurbiprofenEpoprostenolBlood PlateletsDose-Response Relationship, DrugLipoxygenase InhibitorsArachidonic AcidsSodium SalicylatePlatelet Function TestsThromboxane A2Drug Therapy, CombinationDouble-Blind MethodLipoxygenaseSulfonesLactonesEicosanoidsMembrane ProteinsKetoprofenMasoprocolStomach UlcerAsthma, Aspirin-InducedFibrinolytic AgentsThromboxane-A SynthaseDrug InteractionsGastrointestinal HemorrhageProstaglandins ETime FactorsAntipyreticsGastric MucosaHemorrhagePiroxicamPlatelet ActivationBleeding TimeLipoxinsAnticoagulantsHydroxyeicosatetraenoic AcidsWarfarinTablets, Enteric-CoatedDuctus Arteriosus, PatentTolmetinProstaglandin Antagonists4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amineTreatment OutcomeAdministration, OralNitric OxideArachidonate 5-LipoxygenaseThrombosisRisk FactorsIntramolecular OxidoreductasesTherapeutic EquivalencyAnti-Inflammatory AgentsDinoprostDrug Administration ScheduleProstaglandins GMeclofenamic AcidSeminal VesiclesProspective StudiesSulindacKetorolacFeverSulfinpyrazoneDipyridamoleSalicylic AcidMyocardial InfarctionReceptors, Prostaglandin ECross-Over StudiesDrug ResistanceVasodilationArachidonate LipoxygenasesStereoisomerismRats, Sprague-DawleyNitric Oxide SynthaseCells, Cultured5,8,11,14-Eicosatetraynoic Acid